Skip to search formSkip to main contentSkip to account menu

DMS612

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Benzaldehyde Dimethane SulfonateNSC281612

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent
Purpose: DMS612 is a dimethane sulfonate analog with bifunctional alkylating activity and preferential cytotoxicity to human… 
2013
2013
Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice
PurposeBenzaldehyde dimethane sulfonate (DMS612, NSC281612, BEN) is an alkylator with activity against renal cell carcinoma… 
2011
2011
Abstract 5465: Modulation of DMS612 (BEN) pharmacokinetics and metabolism in mice by disulfiram, and aldehyde dehydrogenase inhibitor
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Introduction: DMS612 (NSC 281612, BEN) is an alkylating… 
2010
2010
Abstract 3524: Plasma pharmacokinetics and metabolism of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Introduction: BEN is an alkylating agent in early… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)